207 related articles for article (PubMed ID: 15878583)
1. Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features.
Matsui H; Udaka F; Miyoshi T; Hara N; Tamura A; Oda M; Kubori T; Nishinaka K; Kameyama M
Parkinsonism Relat Disord; 2005 Jun; 11(4):227-32. PubMed ID: 15878583
[TBL] [Abstract][Full Text] [Related]
2. The value of brain perfusion SPECT for differentiation between mildly symptomatic idiopathic Parkinson's disease and the Parkinson variant of multiple system atrophy.
Song IU; Yoo I; Chung YA; Jeong J
Nucl Med Commun; 2015 Oct; 36(10):1049-54. PubMed ID: 26087241
[TBL] [Abstract][Full Text] [Related]
3. Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy.
Murakami N; Sako W; Haji S; Furukawa T; Otomi Y; Otsuka H; Izumi Y; Harada M; Kaji R
J Neurol Sci; 2020 Feb; 409():116627. PubMed ID: 31865188
[TBL] [Abstract][Full Text] [Related]
4. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters.
Van Laere K; Santens P; Bosman T; De Reuck J; Mortelmans L; Dierckx R
J Nucl Med; 2004 Jun; 45(6):933-42. PubMed ID: 15181127
[TBL] [Abstract][Full Text] [Related]
5. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
[TBL] [Abstract][Full Text] [Related]
6. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
7. The utility of cerebral perfusion SPECT analysis using SPM8, eZIS and vbSEE for the diagnosis of multiple system atrophy-parkinsonism.
Sakurai K; Imabayashi E; Ito K; Tokumaru AM; Ozawa Y; Muto M; Nakagawa M; Okita K; Matsukawa N; Shibamoto Y
Ann Nucl Med; 2015 Feb; 29(2):206-13. PubMed ID: 25413272
[TBL] [Abstract][Full Text] [Related]
8. Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.
Pirker W; Asenbaum S; Wenger S; Kornhuber J; Angelberger P; Deecke L; Podreka I; Brücke T
J Nucl Med; 1997 Nov; 38(11):1711-7. PubMed ID: 9374338
[TBL] [Abstract][Full Text] [Related]
9. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease.
Bosman T; Van Laere K; Santens P
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):16-24. PubMed ID: 12483405
[TBL] [Abstract][Full Text] [Related]
10. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of Parkinson's disease and related syndromes using 123I-IMP-SPECT with the ARG method].
Kageyama H; Kikuchi S; Tashiro K
Nihon Rinsho; 1997 Jan; 55(1):238-42. PubMed ID: 9014457
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy.
Oka H; Mochio S; Yoshioka M; Morita M; Onouchi K; Inoue K
Acta Neurol Scand; 2006 Apr; 113(4):221-7. PubMed ID: 16542160
[TBL] [Abstract][Full Text] [Related]
14. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
[TBL] [Abstract][Full Text] [Related]
15. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
[TBL] [Abstract][Full Text] [Related]
16. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.
Pirker W; Asenbaum S; Bencsits G; Prayer D; Gerschlager W; Deecke L; Brücke T
Mov Disord; 2000 Nov; 15(6):1158-67. PubMed ID: 11104200
[TBL] [Abstract][Full Text] [Related]
17. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
[TBL] [Abstract][Full Text] [Related]
18. Brain perfusion differences in parkinsonian disorders.
Kimura N; Hanaki S; Masuda T; Hanaoka T; Hazama Y; Okazaki T; Arakawa R; Kumamoto T
Mov Disord; 2011 Dec; 26(14):2530-7. PubMed ID: 21830234
[TBL] [Abstract][Full Text] [Related]
19. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.
Varrone A; Marek KL; Jennings D; Innis RB; Seibyl JP
Mov Disord; 2001 Nov; 16(6):1023-32. PubMed ID: 11748733
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W
Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
